ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2619

Suicidal Ideation Among Patients With Behcet’s Syndrome

Didem Uzunaslan1, Caner Saygin1, Gulen Hatemi2, Koray Tascilar1, Hasan Yazici3 and Vedat Hamuryudan4, 1University of Istanbul, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 2Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 3Cerrahpasa Medical Faculty University of Istanbul, Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 4Division of Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose:  An increased frequency of depression has been reported in Behcet’s syndrome (BS). While an increased suicidal ideation has been reported in other chronic rheumatologic conditions, this has not been studied in patients with BS. We aimed to evaluate the frequency of suicidal ideation among BS patients and to delineate the factors predicting an increase in suicidal ideation.

Methods: The frequency of suicidal ideation was evaluated with a standard questionnaire that was previously used (2), among BS patients with and without major organ involvement, and ankylosing spondylitis (AS) patients who attended our outpatient clinic for their routine visits and a group of healthy controls. We questioned whether the subjects 1) thought that life was not worth living, 2) thought about ending their lives within the previous year, 3) ever planned to end their lives and if yes, whether they had planned to end their lives before the onset of their disease. In addition, Beck depression inventory (BDI) and Behcet’s disease quality of life (BDQoL) questionnaires were filled. Disease activity was assessed using the Behcet’s disease current activity form (BDCAF) for BS patients and BASDAI and BASFI for AS patients.

Results: We surveyed 240 BS patients who had only mucocutaneous symptoms, 63 BS patients with active major organ involvement (30 eye, 31 vascular, 7 neurologic involvement), 50 patients with AS, and 106 healthy controls (Table). Number of subjects who answered affirmatively to the second and third questions were significantly higher among BS patients with active major organ involvement compared to the other groups (p<0.001 and p=0.002). Among BS patients with active major organ involvement, 9/27 with eye, ¼ with neurologic, 3/27 with vascular, and 3/5 with more than one type of major involvement had thought of ending their lives. 9/27 with eye, 2/4 with neurologic, 3/27 with vascular and 2/5 with more than one type of major involvement had planned to end their lives. BS patients with eye involvement had the highest frequency of answering positively to these 2 questions (p<0.001 for each). None of the drugs that were used seemed to be associated with suicidal ideation. For each of the questions regarding suicidal ideation, the BDCAF, BDQoL and BDI scores of BS patients were higher among those who answered positively. Regardless of suicidal ideation, the BDI scores of BS patients with active major organ involvement were higher than AS patients and healthy controls.

BS major organ (n=63) BS mucocutaneous (n=240) AS (n=50) Healthy controls (n=106) p
M:F 36/27 83/157 14/36 77/29 <0.001
Mean age ± SD 36 ± 12 38.2 ± 11 37.9 ± 10.3 36 ± 10.1 0.218
Thought about ending their lives 16/63 (25.4%) 21/240 (8.8%) 4/50 (8%) 7/106 (6.6%) <0.001
Ever planned to end their lives 16/63 (25.4%) 22/240 (9.2%) 4/50 (8%) 9/106 (8.5%) 0.002
Beck depression inventory scores 16.9 ± 11.4 10.9 ± 9 10.8 ± 10.1 9 ± 7.7 <0.001

Conclusion: The frequency of suicidal ideation is increased among BS patients who have major organ involvement. This increase in suicidal ideation is correlated with higher disease activity and increased depression scores. Longitudinal studies are required for determining whether the frequency of suicidal ideation decreases with treatment and improvement in disease activity.


Disclosure:

D. Uzunaslan,
None;

C. Saygin,
None;

G. Hatemi,
None;

K. Tascilar,
None;

H. Yazici,
None;

V. Hamuryudan,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/suicidal-ideation-among-patients-with-behcets-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology